Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Plasma levels of coagulation factors VIII and IX and risk of venous thromboembolism: Systematic review and meta-analysis.

Thrombosis research·2023
Same author

Thrombosis in Scotland, 1800-1960.

The journal of the Royal College of Physicians of Edinburgh·2022
Same author

The birth of British geriatric medicine: further information on Scotland.

The journal of the Royal College of Physicians of Edinburgh·2021
Same author

Correction to History of the West of Scotland Haemophilia Centre, Glasgow, 1950-2019.

The journal of the Royal College of Physicians of Edinburgh·2021
Same author

History of the West of Scotland Haemophilia Centre, Glasgow, 1950-2019.

The journal of the Royal College of Physicians of Edinburgh·2020
Same author

Troponin and BNP are markers for subsequent non-ischaemic congestive heart failure: the Caerphilly Prospective Study (CaPS).

Open heart·2018

Related Experiment Video

Updated: Jun 23, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

Factor IX and deep vein thrombosis.

Gordon Lowe

    Haematologica
    |May 2, 2009
    PubMed
    Summary
    This summary is machine-generated.

    Elevated coagulation factors increase thrombosis risk. This article explores new research on mechanisms and future directions for thrombosis research.

    More Related Videos

    Deep Vein Thrombosis Induced by Stasis in Mice Monitored by High Frequency Ultrasonography
    06:44

    Deep Vein Thrombosis Induced by Stasis in Mice Monitored by High Frequency Ultrasonography

    Published on: April 13, 2018

    A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
    10:26

    A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

    Published on: June 2, 2015

    Related Experiment Videos

    Last Updated: Jun 23, 2026

    Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
    13:08

    Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

    Published on: September 9, 2012

    Deep Vein Thrombosis Induced by Stasis in Mice Monitored by High Frequency Ultrasonography
    06:44

    Deep Vein Thrombosis Induced by Stasis in Mice Monitored by High Frequency Ultrasonography

    Published on: April 13, 2018

    A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
    10:26

    A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

    Published on: June 2, 2015

    Area of Science:

    • Hematology
    • Thrombosis Research
    • Coagulation Science

    Background:

    • Elevated levels of specific coagulation factors are linked to a higher risk of developing thrombosis.
    • Understanding these associations is crucial for developing effective preventative and therapeutic strategies.

    Discussion:

    • This perspective article critically examines the implications of Bezemer and coworkers' report.
    • It explores how these findings advance our comprehension of the underlying mechanisms of thrombosis.

    Key Insights:

    • The report by Bezemer et al. offers novel insights into coagulation factor roles in thrombosis.
    • Identifying key mechanisms can guide the development of targeted anticoagulant therapies.

    Outlook:

    • Future research should focus on elucidating the precise molecular pathways involved in factor-mediated thrombosis.
    • Investigating these mechanisms will pave the way for personalized risk assessment and treatment strategies for thrombotic disorders.